Ghost Tree Capital, LLC Curis Inc Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$6.94 - $8.85 $1.72 Million - $2.19 Million
-247,124 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$7.45 - $16.27 $1.33 Million - $2.89 Million
-177,876 Reduced 41.85%
247,124 $1.99 Million
Q4 2020

Feb 16, 2021
BUY
$1.08 - $8.2 $459,000 - $3.48 Million
425,000 New
425,000 $3.48 Million

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $409M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email